Not all people with CLL require therapy. Irrespective of all modern advancements, the iwCLL however suggests watchful observation for patients with asymptomatic disorder.86 This recommendation is based on at the very least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). ddbola selalu memberikan https://carsonv368xxz1.blogoscience.com/profile